Orally bioavailable small-molecule CD73 inhibitor (OP-5244) reverses immunosuppression through blockade of adenosine production

Du X, Moore J, Blank BR, Eksterowicz J, Sutimantanapi D, Yuen N, Metzger T, Chan B, Huang T, Chen X, Chen Y, Duong F, Kong W, Chang JH, Sun J, Zavorotinskaya T, Ye Q, Junttila MR, Ndubaku C, Friedman LS, Fantin VR & Sun D
Choose the citation style.
Du, X., Moore, J., Blank, B. R., Eksterowicz, J., Sutimantanapi, D., Yuen, N., … Sun, D. (2020). Orally bioavailable small-molecule CD73 inhibitor (OP-5244) reverses immunosuppression through blockade of adenosine production. Journal of Medicinal Chemistry, 63(18), 10433-10459. https://doi.org/10.1021/acs.jmedchem.0c01086